Sat.Nov 28, 2020 - Fri.Dec 04, 2020

article thumbnail

Colchicine added to UK’s COVID-19 ‘RECOVERY’ trial

Pharma Times

Commonly used anti-inflammatory drug added to list of potential treatments

181
181
article thumbnail

iRhythm digital heart monitoring service backed by NICE

pharmaphorum

A heart monitor developed by iRhythm has become the first product to be endorsed by NICE in a pilot project covering digital health technologies. In new guidance, the health technology assessment (HTA) agency has recommended iRhythm’s Zio XT service for detecting abnormal heart rhythms – provided NHS organisations that deploy it collect evidence of its benefits.

Hospitals 136
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

London A.I. Lab Claims Breakthrough That Could Accelerate Drug Discovery

NY Times

Researchers at DeepMind say they have solved “the protein folding problem,” a task that has bedeviled scientists for more than 50 years.

123
123
article thumbnail

Health Canada consults on transition of interim order drugs, vaccines, and medical devices to permanent approval pathways

Pharma in Brief

As we have previously reported, the Minister of Health ( Minister ) approved the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 ( Interim Order for Drugs and Vaccines ) on September 16, 2020 and the Interim order respecting the importation and sale of medical devices for use in relation to COVID-19 ( Interim Order for Medical Devices ) on March 18, 2020. .

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

PureTech launches phase II ‘long COVID’ drug trial

Pharma Times

LYT-100 will be evaluated in patients with persistent symptoms caused by COVID-19

159
159
article thumbnail

Pfizer cut vaccine production targets because of raw material shortage – reports

pharmaphorum

Pfizer slashed its production targets for its COVID-19 vaccine because of a lack of raw materials for its supply chain, according to press reports. The big pharma has said in recent weeks that it expects to produce 50 million doses of the vaccine it developed with the German BioNTech, down from an earlier target of 100 million doses. That’s enough to inoculate 25 million people as the dosing schedule involves two shots three weeks apart.

Vaccines 125

More Trending

article thumbnail

COVID-19 collaboration to study patient risk via blood

Outsourcing Pharma

Health tech specialists GoodCell are working with the New York Blood Center to identify COVID-19 patients with elevated risk of adverse clinical outcomes.

92
article thumbnail

COVID-19 could cause long-term lung damage, research finds

Pharma Times

Research conducted at Oxford University used new scanning method

149
149
article thumbnail

Healthware Group buys Finnish digital agency Make Helsinki

pharmaphorum

Healthcare agency, consultancy and digital health group Healthware Group has acquired Finland-based digital service development and creative agency Make Helsinki. The acquisition builds on prior collaborations between the two organisations, including in best-in-class full-service agency offerings, digital transformation, technology/enterprise solutions and corporate venturing.

article thumbnail

New Guidelines Cover Opioid Use After Children’s Surgery

NY Times

Parents should not be afraid of managing the child’s pain with opioids when they are needed, but should make sure a child does not have access to leftover doses.

60
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

COVID-19 fueling decentralized trial surge: Oracle survey

Outsourcing Pharma

A recent survey conducted by Oracle reveals trial professionalsâ thoughts, feelings and behavior around decentralized research in the face of the pandemic.

80
article thumbnail

Bayer inks deal with Blackford Analysis to develop radiology AI platform

Pharma Times

Agreement will aim to develop a platform to support radiologists' decision-making

136
136
article thumbnail

Valneva accelerates Lyme disease vaccine R&D project with Pfizer

pharmaphorum

Valneva has said it plans to accelerate research into its Lyme disease vaccine candidate VLA15, bringing forward a trial including children into the first quarter of 2021. Subject to approval from regulators the vaccine specialist said it plans the trial known as VLA15-221 as a randomised, observer-blind phase 2 study including around 600 healthy people aged 5-65 years of age.

Vaccines 119
article thumbnail

China Poised to Be First to Distribute Virus Vaccine in Latin America, U.S. Official Says

NY Times

China, which has been expanding its presence in the region, is likely to beat the United States in its own backyard with vaccine diplomacy as Washington looks “at taking care of the U.S. first.”.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Dive into the digital evolution of clinical trials

Outsourcing Pharma

Taking place December 9, the Digital Advances in Clinical Trials webinar covers notable advances in clinical trial technology, and the future of the field.

59
article thumbnail

Dupixent approved in EU for atopic dermatitis in children

Pharma Times

First biologic to be approved for children aged six to 11 years with condition

128
128
article thumbnail

‘Knowledge is power’ for rare diseases and NAbs

pharmaphorum

Cure Rare Disease’s Rich Horgan discusses the importance of preclinical NAbs screening and helping rare disease patients better understand their eligibility for gene therapies. Neutralising antibodies (NAbs) present a unique challenge to researchers looking to treat patients with AAV treatment. As AAV is a virus derived from the common cold, the immune system can easily have levels of pre-existing NAbs that will recognise and neutralise AAV, rendering it ineffective.

article thumbnail

Baricitinib: Doctors Are Skeptical of This Covid-19 Drug From Eli Lilly

NY Times

Baricitinib, an arthritis drug made by Eli Lilly, may reduce recovery time by a day, but costs about $1,500 and comes with side effects.

55
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Janssen partners with Koa Health on digital depression treatments

Outsourcing Pharma

The global pharma firm will work with the digital mental health solutions specialist on solutions for treatment-resistant depressive order patients.

55
article thumbnail

AbbVie partners with Frontier Medicines on protein degrader development

Pharma Times

Partnership will seek to develop small molecules for oncology/immunology targets

128
128
article thumbnail

J&J files lung cancer bispecific amivantamab for FDA approval

pharmaphorum

Johnson & Johnson has filed its bispecific antibody amivantamab to the FDA, hoping to muscle into the big market for drugs that are used to treat EGFR-positive non-small cell lung cancer (NSCLC). J&J’s Janssen unit is seeking approval of the drug in a specific patient group – those with exon 20 insertion mutations whose disease has progressed despite first-line chemotherapy.

article thumbnail

Coronavirus Vaccine in New York: What to Know

NY Times

If approved, the first batch of vaccine could arrive in the state on Dec. 15, the governor said, and contain enough doses for 170,000 people.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Medable lands $91m to fuel decentralized trial tech

Outsourcing Pharma

The Series C funding will be used to help accelerate the research industryâs adoption of decentralized and digital clinical trial technology.

54
article thumbnail

Researchers warn pandemic could delay cancer advances ‘by almost a year’

Pharma Times

Survey included input from scientists at The Institute of Cancer Research, London

125
125
article thumbnail

Kayentis raises €7m for its digital trial engagement platform

pharmaphorum

French tech company Kayentis has raised €7 million in private funding that will be invested in its digital platform for clinical trials. The Grenoble-based company operates in the electronic Clinical Outcome Assessment (eCOA) market, which covers areas like patient and clinician reported outcomes, automatic remote testing, and patient diaries through a combination of web and mobile tools.

90
article thumbnail

CVS to Give Out Covid-19 Treatment in Nursing Homes

NY Times

The three-month pilot program involves just 1,000 doses of the medication in seven big cities. It’s not clear how much impact that will have as demand surges.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Latest FDA COVID-19 news

Outsourcing Pharma

As the pandemic continues to impact the globe, the agency has kept busy issuing EUAs for potential treatments, and cited sellers of unapproved treatments.

53
article thumbnail

DSRU plans ‘post-authorisation’ study of COVID-19 vaccines in the UK

Pharma Times

Drug Safety Research Unit set to conduct active surveillance study on COVID-19 vaccines

Vaccines 125
article thumbnail

PureTech begins trial of potential ‘Long COVID’ drug as cases mount

pharmaphorum

As the pandemic drags on there are increasing concerns about “Long COVID” – where symptoms persist long after the initial infection has been fought off. PureTech has joined the effort to find ways to treat the scarring and inflammation that are thought to cause the ongoing symptoms such as shortness of breath and fatigue. After promising results in an early stage study, the company has begun a phase 2 trial of its LYT-100 (deupirfenidone) in Long COVID respiratory complications and related seque

88
article thumbnail

Which pharmaceutical companies have the most injectable dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most injectable dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most injectable dosed drugs…. The post Which pharmaceutical companies have the most injectable dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.